Table 4.

Sexual attempts, satisfaction, and ability to achieve orgasm over a 2‐week period

ITT‐ALL SUBJECTS (N = 16)	# Sexual attempts	# Enjoyable	# Orgasms
Baseline visit	3.5 (SD = 2.8)	1.7 (SD = 1.6)	1.3(SD = 1.5)
Final visit	4.0 (SD = 3.0)	3.0 (SD = 2.4)	1.8 (SD = 2.8)
Significance	z =−0.88; P= 0.38	z =−1.83; P= 0.07	z =−0.81; P= 0.42
ITT‐LOW DOSE (1.5 g/day) (n = 7)
Baseline visit	4.0 (SD = 3.4)	2.3 (SD = 1.9)	1.3 (SD = 1.6)
Final visit	3.3 (SD = 1.7)	2.6 (SD = 1.8)	1.0 (SD = 1.3)
Significance	z =−0.42; P= 0.67	z =−0.17; P= 0.86	z =−0.41; P= 0.68
ITT‐HIGH DOSE (3.0 g/day) (n = 9)
Baseline visit	3.1 (SD = 2.4)	1.2 (SD = 1.2)	1.3 (SD = 1.5)
Final visit	4.6 (SD = 3.7)	3.4 (SD = 2.9)	2.5 (SD = 3.6)
Significance	z =−1.98; P= 0.048*	z =−2.34; P= 0.019*	z =−1.40; P= 0.16

COMPLETERS‐ALL (n = 10)	# Sexual Attempts	# Enjoyable	# Orgasms
Baseline visit	3.1 (SD = 3.1)	1.5 (SD = 1.6)	0.8 (SD = 0.9)
Final visit	2.6 (SD = 1.3)	2.0 (SD = 1.4)	1.2 (SD = 13)
Significance	z =−0.24; P= 0.81	z =−0.62; P= 0.54	z =−0.88; P= 0.38
COMPLETERS‐LOW DOSE (1.5 g/day) (n = 6)
Baseline visit	4.0 (SD = 3.7)	2.0 (SD = 1.9)	0.8 (SD = 1.2)
Final visit	2.8 (SD = 1.3)	2.2 (SD = 1.6)	1.2 (SD = 1.3)
Significance	z =−0.68; P= 0.50	z =−0.11; P= 0.92	z =−0.38 P= 0.71
COMPLETERS‐HIGH DOSE (3.0 g/day) (n = 4)
Baseline visit	1.8 (SD = 1.0)	0.8 (SD = 0.5)	0.8 (SD = 0.5)
Final visit	2.3 (SD = 1.3)	1.8 (SD = 1.3)	1.3 (SD = 1.5)
Significance	z =−1.00; P= 0.32	z =−1.30; P= 0.19	z =−0.82; P= 0.41

*Statistically significant (P < 0.05).